Effector mechanisms in HIV-1 infected Elite Controllers: Highly Active Immune Responses?

Por Blankson, Joel N
Publicado em 2009

MHC class II genotype and the control of viremia in HIV-1–infected individuals on highly active antiretroviral therapy

Por Blankson, Joel N., Siliciano, Robert F.
Publicado em 2001

HIV-1 and Hematopoietic Stem Cell Transplantation

Por Durand, Christine, Ambinder, Richard, Blankson, Joel, Forman, Stephen
Publicado em 2012

HIV Type 1-Mediated Downregulation of HLA-B*57/B*5801 Proteins on Elite Suppressor CD4(+) T Cells

Por Sampah, Maame Efua S., Ceccato, Christina M., Blankson, Joel N.
Publicado em 2011

Primary CD8(+) T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4(+) T cells

Por Buckheit, Robert W, Siliciano, Robert F, Blankson, Joel N
Publicado em 2013

Developing strategies for HIV-1 eradication

Por Durand, Christine M., Blankson, Joel N., Siliciano, Robert F.
Publicado em 2012

Finding A Cure for HIV-1 Infection

Por Blankson, Joel N., Siliciano, Janet D., Siliciano, Robert F.
Publicado no Infect Dis Clin North Am (2014)

Candida Esophagitis in a Human Immunodeficiency Virus-1-Positive Elite Controller With Hepatitis C Virus Cirrhosis

Por Chen, Anders, Shieh, Eugenie, Brinkley, Sherilyn, Blankson, Joel N.
Publicado no Open Forum Infect Dis (2014)

Effective Downregulation of HLA-A*2 and HLA-B*57 by Primary Human Immunodeficiency Virus Type 1 Isolates Cultured from Elite Suppressors

Por Nou, Eric, Zhou, Yan, Nou, Damaris D., Blankson, Joel N.
Publicado em 2009

Inhibitory Potential of Subpopulations of CD8(+) T Cells in HIV-1-Infected Elite Suppressors

Por Buckheit, Robert W., Salgado, Maria, Silciano, Robert F., Blankson, Joel N.
Publicado em 2012

Comparative Analysis of the Capacity of Elite Suppressor CD4(+) and CD8(+) T Cells To Inhibit HIV-1 Replication in Monocyte-Derived Macrophages

Por Walker-Sperling, Victoria E. K., Buckheit, Robert W., Blankson, Joel N.
Publicado em 2014

Maintenance of viral suppression in HIV-1–infected HLA-B*57(+) elite suppressors despite CTL escape mutations

Por Bailey, Justin R., Williams, Thomas M., Siliciano, Robert F., Blankson, Joel N.
Publicado em 2006

A Comparison of Viral Loads between HIV-1–Infected Elite Suppressors and Individuals Who Receive Suppressive Highly Active Antiretroviral Therapy

Por Dinoso, Jason B., Kim, Scott Y., Siliciano, Robert F., Blankson, Joel N.
Publicado em 2008

CD4(+) T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors

Por O'Connell, Karen A., Rabi, S. Alireza, Siliciano, Robert F., Blankson, Joel N.
Publicado em 2011

Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients

Por Witwer, Kenneth W, Watson, Andria K, Blankson, Joel N, Clements, Janice E
Publicado em 2012

CD8(+) T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants

Por Pohlmeyer, Christopher W, Buckheit, Robert W, Siliciano, Robert F, Blankson, Joel N
Publicado em 2013

Viral suppression of multiple escape mutants by de novo CD8(+ )T cell responses in a human immunodeficiency virus-1 Infected elite suppressor

Por O'Connell, Karen A, Hegarty, Robert W, Siliciano, Robert F, Blankson, Joel N
Publicado em 2011

Evolution of an Attenuated HIV-1 Isolate in an Elite Suppressor

Por Salgado, Maria, Gandhi, Shiv, Buckheit, Robert W., Berkenblit, Gail V., Blankson, Joel N.
Publicado em 2014

Immune Control Despite Protracted Lymphopenia After Chemoradiation in an Elite Controller

Por Reiss, Kim A., Jackson, Dvone C., Piotrowski, Anna, Grossman, Stuart, Blankson, Joel N.
Publicado no Open Forum Infect Dis (2016)

The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication

Por Walker-Sperling, Victoria E., Pohlmeyer, Christopher W., Tarwater, Patrick M., Blankson, Joel N.
Publicado no EBioMedicine (2016)